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Abstract BACKGROUND CONTEXT: Several randomized controlled trials (RCTs) have compared patient
outcomes of anterior (cervical) interbody fusion (AIF) with those of total disc arthroplasty (TDA).
Because RCTs have known limitations with regard to their external validity, the comparative effec-
tiveness of the two therapies in daily practice remains unknown.
PURPOSE: This study aimed to compare patient-reported outcomes after TDA versus AIF based
on data from an international spine registry.
STUDY DESIGN AND SETTING: A retrospective analysis of registry data was carried out.
PATIENT SAMPLE: Inclusion criteria were degenerative disc or disc herniation of the cervical
spine treated by single-level TDA or AIF, no previous surgery, and a Core Outcome Measures Index
(COMI) completed at baseline and at least 3 months’ follow-up. Overall, 987 patients were identified.
OUTCOME MEASURES: Neck and arm pain relief and COMI score improvement were the outcome
measures.
METHODS: Three separate analyses were performed to compare TDA and AIF surgical out-
comes: (1) mimicking an RCT setting, with admission criteria typical of those in published RCTs, a
1:1 matched analysis was carried out in 739 patients; (2) an analysis was performed on 248 patients
outside the classic RCT spectrum, that is, with one or more typical RCT exclusion criteria; (3) a
subgroup analysis of all patients with additional follow-up longer than 2 years (n=149).
RESULTS: Matching resulted in 190 pairs with an average follow-up of 17 months that had no
residual significant differences for any patient characteristics. Small but statistically significant dif-
ferences in outcome were observed in favor of TDA, which are potentially clinically relevant. Subgroup
analyses of atypical patients and of patients with longer-term follow-up showed no significant dif-
ferences in outcome between the treatments.
CONCLUSIONS: The results of this observational study were in accordance with those of the pub-
lished RCTs, suggesting substantial pain reduction both after AIF and TDA, with slightly greater
benefit after arthroplasty. The analysis of atypical patients suggested that, in patients outside the spec-
trum of clinical trials, both surgical interventions appeared to work to a similar extent to that shown
for the cohort in the matched study. Also, in the longer-term perspective, both therapies resulted in
similar benefits to the patients. © 2015 Elsevier Inc. All rights reserved.
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Introduction
The neurologic symptoms and neck pain associated with
disc degeneration of the cervical spine can be treated surgi-
cally using either the established standard procedure of anterior
interbody fusion (AIF) or the more recently introduced
total disc arthroplasty (TDA). The evidence regarding the
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comparative effectiveness of these surgical procedures has been
summarized recently in a Cochrane Review [1]. The review
included nine randomized controlled trials (RCTs), five of
which were considered to have a low risk of bias [2–6]. It
identified evidence for a small but statistically significant dif-
ference between the treatments in the alleviation of arm pain,
neck-related function, and neurologic outcome, all in favor
of arthroplasty [1]. Although statistically significant, the effect
sizes were not clinically relevant. Based on these results, the
reviewers concluded that at this point in time both treat-
ments could be considered valid therapeutic options. They
also cautioned that, as the available RCTs only included follow-
up periods of up to 2 years, the hypothesis that TDA results
in a reduced incidence of secondary symptoms at adjacent
levels would require evaluation in future updates of the review
once the results of long-term studies were available.
Randomized control trials have an important limitation in
that they often define narrow admission criteria which may
not be applicable to daily clinical practice. For instance, some
studies only recruited patients younger than 60 years [7,8],
limited the treated segments to C3–C7 [2,3,7–12], or ex-
cluded marked spondylosis [2,10,11], trauma [5,7,8] or
spondylolisthesis, which are sometimes considered
contraindications for TDA. Such restrictions are common for
RCTs in an effort to examine treatment effects under ideal
circumstances. Although these trials provide evidence about
the relative efficacy of treatments in selected patients, addi-
tional studies may be needed that measure the relative
effectiveness of the treatments in broader populations [13,14].
In doing so, they serve to assess the external validity of the
results of RCTs.
The purpose of this study is to demonstrate how data from
a surgical registry can be used to supplement the evidence
from RCTs with regard to the outcomes after different types
of surgery for degenerative cervical spine disease. The Spine
Tango registry collects real-world data of patients undergo-
ing surgery of the spine, without the restrictions inherent in
RCTs, and some participating clinics follow their patients for
a long period of time. Using such prospective cohorts, well
designed and carefully executed observational studies can help
to answer clinical questions that go beyond the evidence pre-
sented by RCTs [15,16]. Spine Tango collects detailed clinical
data of patients undergoing TDA and AIF, among other treat-
ments. With the careful application of matching algorithms,
a quasi-experimental comparison of the two surgical groups
can be achieved to confirm (or refute) RCT results [17].
Registry-based observational studies can also serve to de-
scribe the surgical outcome of a broader spectrum of patients
outside the narrow admission criteria of RCTs. Finally, the
registry gives us the opportunity to perform longer-term ef-
fectiveness studies of the surgical treatments.
The aims of this paper were threefold. In a first study we
applied the admission criteria used in the available RCTs and
conducted a propensity score-adjusted outcome analysis to
evaluate whether this design produces short-term results similar
to those of the RCTs, for the comparison of TDA and AIF.
We then analyzed the comparative clinical outcome (for TDA
vs. AIF) of patients typically excluded from the RCTs pub-
lished to date, but present in the registry. Third, we evaluated
the mid to long-term effects of TDA versus AIF in all pa-
tients with follow-up longer than 2 years.
Materials and methods
Spine Tango forms and study cohort
The physician-based surgery form of the registry con-
tains detailed information on diagnosis, the surgical procedure,
and surgical and general complications. In addition to these
surgical records, patients are asked to complete the self-
reported Core Outcome Measures Index (COMI) questionnaire
which includes two graphic rating scales (GRS 0–10 points)
for neck pain and arm pain [18]. The COMI form is the of-
ficial patient-reported outcome instrument of the Spine Tango
registry [18,19] .
None of the centers participating in Spine Tango were in-
volved in any of the RCTs included in the Cochrane review
[1]. The registry database was queried in November 2014 for
cases with a diagnosis of single-level cervical spine degen-
erative disc disease, disc herniation, or black disc, treated either
by TDA or AIF. The inclusion criteria were as follows: most
severely affected segment between C3–C4 and C7T1T1, in-
clusive; no previous surgical treatment of the spine; a baseline
COMI; and at least one follow-up COMI completed between
3 months and 2 years postoperatively. If multiple follow-up
forms were available for a patient within this time period, the
latest form was selected for analysis. Patients who had un-
dergone posterior surgical procedures or whose ASA status
was marked as “unknown” in the surgery form were ex-
cluded from the analysis.
Outcome measures
The outcome measures were postoperative neck and arm
pain and COMI score, as well as neck and arm pain relief
and COMI score improvement, with “responders” being
defined as those achieving a minimum clinically important
change (MCIC) of 2 points in each case [20].
Matching study
For the first study we applied the following exclusion cri-
teria to the Spine Tango cohort to reflect the criteria applied
in the published RCTs: age ≥60 years, follow-up time >2 years,
treated segment C7–T1, diagnosis of spondylosis, trauma, facet
joint degeneration, or spondylolisthesis. Due to incompati-
bility across different generations of the surgery form,
information on spondylosis was missing in 40% and that on
facet joint degeneration in 60% of the study cohort. In these
cases, we assumed the information to be missing at random
and calculated the proportions of spondylosis and of facet joint
degeneration based on the available data. The data on the re-
maining additional exclusion criteria were complete.
Published in final edited form as: Spine J. 2016 Feb;16(2):136-45. doi: 10.1016/j.spinee.2015.11.056.
With this restricted sample, we performed a TDA-versus-
AIF matched analysis to mimic an RCT setting. The propensity
score method was used to adjust for confounding, as de-
scribed in detail by Rosenbaum and Rubin [21]. In brief, an
individual’s propensity score is defined as the conditional prob-
ability of their receiving TDA as opposed to AIF surgery, given
the observed covariates (such as age, gender, previous treat-
ment, American Society of Anesthesiologists (ASA) score,
etc.). Two patients with the same propensity score have an
equal estimated probability of receiving TDA or AIF: if one
receives TDA and the other AIF, the exposure allocation can
be considered random, conditional on the observed covariates.
Therefore, akin to an RCT, there is balance of the covariates
between exposure groups after adjusting for the propensity
score. The important difference between propensity score ad-
justment and RCTs is that the latter are able to balance both
measured and unmeasured covariates. Propensity scores can
only control for the measured covariates.
The individual propensity scores were obtained from a mul-
tivariable logistic regression model with the following
covariates: baseline age (continuous), gender (male or female),
degenerative disc disease (yes or no), disc herniation (yes or
no), previous conservative treatment (none, <6 months, 6–12
months, >12months), ASA status (ASA 1, ASA 2, >ASA 2),
segment (C3–C4, C4–C5, C5–C6, C6–C7), preoperative neck
and arm pain scores (continuous), COMI score (continu-
ous), and length of COMI follow-up in days (continuous).
The propensity scores were then fed into a greedy matching
algorithm for 1:1 TDA-to-AIF matching, using the
“OneToManyMTCH” SAS Macro presented by Parsons [22].
For the continuous study outcomes, mean differences and
95% confidence intervals (CIs) between TDA and AIF groups
were calculated. In addition, differences between the treat-
ment groups in the proportion of responders (those achieving
the MCIC) were expressed as relative risks (RRs) and 95%
CIs and the number needed to treat (NNT) where appropriate.
Atypical patients study
In the second study, an analysis of patients outside the
classic RCT spectrum was performed. This study sample com-
prised all (atypical) patients from the overall cohort that were
not used in the matching study because they had one or more
of the exclusion criteria defined in the first study. A detailed
description of the characteristics of these patients was given
to demonstrate the extent to which these patients differed from
the RCT patient population.
For the continuous study outcomes, multivariable linear
regression models, allowing for significant baseline differ-
ences between the treatment groups, were fitted to assess the
relative effectiveness of the two types of treatment. Similar-
ly, multivariable logistic regression models, controlling for
significant between-group baseline differences, were built to
obtain adjusted estimates of the proportion of responders in
the two treatment groups, which were expressed as odds ratios
(ORs) and 95% CIs and the NNT where appropriate.
Long-term study
Lastly, a subgroup analysis was carried out of all pa-
tients with additional longer-term follow-up, that is, at least
2 years postoperatively. As in the atypical patients study, the
relative effectiveness of the two types of treatment was as-
sessed using multivariable regression analyses, allowing for
significant between-group baseline differences.
The stability of all the multivariable regression models was
assessed using the Hosmer and Lemeshow goodness-of-fit test.
The significance level was set to 0.05 throughout the study.
All statistical analyses were conducted using SAS 9.4 (SAS
Institute, Inc., Cary, NC, USA).
Results
Out of a total of more than 75,000 Spine Tango surgery
forms in the registry, the selection process for the present study
resulted in a cohort of 987 patients undergoing TDA or AIF
surgery. Fig. 1 shows the study profile of the included pa-
tients. Overall, 35 hospitals from 8 countries (Australia,
Belgium, Germany, Poland, Slovenia, Switzerland, UK, and
the USA) contributed their data to this study. TDA was docu-
mented in 30 hospitals from 8 countries. AIF was documented
in 16 hospitals from 5 countries.
Matching study
Out of the 987 patients, 739 cases were identified as being
representative of RCT patients. Of these, 190 patients un-
derwent TDA and 549 AIF. All TDA cases found an AIF
counterpart, and the matching process resulted in 2 groups
with 190 patient pairs with well-balanced patient character-
istics (Table 1), leaving 359 AIF patients without a partner.
The outcome analysis in the matched patients produced
statistically significant group differences for postoperative neck
pain (mean difference [MD] 0.6 points; 95% CI 0.0, 1.2;
p=.04), arm pain (MD 0.7; 95% CI 0.1, 1.3; p=.02), and COMI
score (MD 0.8 points; 95% CI 0.2, 1.4; p=.01), all in favor
of TDA (Table 2; Fig. 2). Furthermore, the COMI change score
was significantly different in favor of TDA (MD −1.0; 95%
CI −1.6, −0.4; p<.01). Change scores for neck pain (MD −0.5;
95% CI −1.1, 0.2; p=.16) and arm pain (MD −0.7; 95% CI
−1.5, 0.0; p=.06) did not differ significantly.
The probability of being a responder (ie, achieving an MCIC
score of 2 points) for neck pain relief was not significantly
different for TDA (62.1%) compared with AIF (57.9%) (RR
1.07; 95% CI 0.91, 1.26; p=.40). The likelihood of being a
responder was significantly greater for TDA than for AIF for
both arm pain relief (78.4% vs. 67.4%, respectively; RR 1.16;
95% CI 1.03, 1.32; p=.02; NNT 10; 95% CI 5, 46) and for
COMI score improvement (81.6% vs. 67.9%, respectively;
RR 1.20; 95% CI 1.07, 1.35; p<.01; NNT 8; 95% CI 5, 20).
Atypical patients study
There were 248 patients who did not meet the common
RCT inclusion criteria, representing 25.1% of the overall study
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cohort. Table 3 shows that most of these patients were ex-
cluded from the matching study because of age ≥60 years or
a diagnosis of spondylosis. Patients undergoing TDA were
generally younger and less likely to have undergone surgery
at C7–T1 compared with the AIF patients.
No significant differences in outcome were observed
between the two treatment groups (Table 2; Fig. 2). The prob-
ability of being a responder (achieving MCIC) with regard
to neck pain relief was 59.3% after TDA and 61.5% after AIF.
After allowing for patient age, operated segment, and follow-
up time, the OR for being a responder after TDA versus AIF
was 0.92 (95% CI 0.39, 2.16; p=.84). For arm pain relief, the
figures were 63.0% and 66.5%, respectively (OR 1.03; 95%
CI 0.42, 2.53; p=.94), and for COMI, 66.7% and 67.4%, re-
spectively (OR 1.22; 95% CI 0.49, 3.03; p=.68).
Longer-term follow-up study
In a total of 149 patients from the overall cohort, an
additional longer-term COMI follow-up of more than 2
years after surgery was available. These patients had been
treated in seven hospitals in five countries. The mean
follow-up time was 55.0 (±12.2) months (range 27.0–76.5
months).
The characteristics of the patients in the longer-term
follow-up study are shown in Table 4. Patients who had
received AIF were significantly older than patients in the
TDA group. Compared with the AIF group, TDA patients
had significantly lower COMI scores and significantly greater
COMI score improvements at the short-term follow-up
(Table 2; Fig. 2). However, at the longer-term follow-up,
the differences between the treatment groups failed to reach
significance.
At the longer-term follow-up, the probability of being a
responder (achieving MCIC) with regard to neck pain relief
was 63.6% for TDA and 64.9% for AIF. After allowing for
patient age, the OR for being a responder after TDA versus
AIF was 1.02 (95% CI 0.50, 2.11; p=.95). For arm pain relief
the corresponding figures were 80.0% and 64.9%, respec-
tively (OR 2.25; 95% CI 1.00, 5.09; p=.05; NNT 7; 95% CI
Spine Tango surgery forms 
N=75’890 
Excluded 
- Location not cervical (N=63’896; 84.2%) 
- Wrong diagnosis (N=4’344; 36.2%) 
- multilevel procedure (N=3’291; 43.0%) 
- had previous surgery (N=643; 14.8%) 
- no AIF/TDA surgery (N=366; 9.8%) 
- had posterior measures (N=77; 2.3%) 
- ASA class unknown (N=474; 14.5%) 
- no baseline OR FU (3mo-2y) COMI form (N=1’812; 
64.7%) 
Overall cohort 
N=987 
1. Matching study
N=987 
2. Atypical patients study
N=987 
3. Long-term study
N=987 
Excluded 
- age≥60 OR 
- spondylosis OR 
- C7/Th1 OR 
- trauma OR 
- spondylolisthesis OR 
- facet joint degeneration 
(N=248; 25.1%) 
Study cohort 
N=739 
TDA: n=190 
AIF: n=190 
Study cohort 
N=248 
TDA: n=27 
AIF: n=221 
Excluded 
- used in matching study 
(N=739; 74.9%) 
Study cohort 
N=149 
TDA: n=55 
AIF: n=95 
Excluded 
- no long-term 
(> 2y) follow-
ups (N=838; 
84.9%) 
Fig. 1. Study profile of the included patients.
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4, 126), and for COMI, 76.4% and 68.1%, respectively (OR
1.44; 95% CI 0.65, 3.18; p=.36).
Discussion
Summary of results
In this analysis of surgical outcomes after TDA and AIF
we demonstrate how data from the Spine Tango registry can
be used to present evidence that both complements and supple-
ments that provided by RCTs. The first study, a matched
comparison of patients who were representative of the type
recruited into the RCTs published to date, showed that the
outcomes for TDA were slightly but statistically signifi-
cantly superior to those for AIF. Our second study examined
patients that are typically excluded from the RCTs (eg, due
to restrictions on age or particular diagnoses) but were docu-
mented in Spine Tango. Here, no differences between the
surgical groups were observed in the treatment effects. For
the third study, we analyzed the surgical outcome of regis-
try patients with longer-term follow-up. Although there were
clear trends for superior results with TDA, only borderline
statistically significant differences between TDA and AIF were
observed for any of the outcomes.
Clinical implications
The matched study confirmed the main results of the ex-
isting RCTs that there is a tendency (sometimes statistically
significant) for clinical results to be in favor of TDA. The post-
operative pain levels and COMI scores were significantly lower
in the TDA group, showing slightly larger differences between
the surgical groups than those in the Cochrane review. Al-
though the differences in our study were still relatively small,
more than 10% more of the patients in the TDA group achieved
the MCIC for arm pain and COMI compared with the AIF
group. The RR of being a responder in relation to arm pain
(RR=1.16) and COMI score (RR=1.20) was small, with cor-
responding NNTs of 10 and 8. These NNTs are nonetheless
potentially clinically relevant [23], especially in view of the
literature reporting no greater harms in TDA than AIF [24];
however, they should be confirmed in future studies in which
the relative costs and risks of each treatment (number needed
to harm) are directly evaluated. Such studies should also be
of a larger size, to obtain tighter confidence intervals around
the NNTs.
The study of atypical patients suggests that, in patients
outside the spectrum of clinical trials, both surgical inter-
ventions appear to work to a similar extent. No superiority
of TDA could be observed. Fig. 2 (left column) shows that
all patients achieved comparable levels of pain alleviation and
COMI score improvement in the first 2 years after surgery.
The analysis of long-term outcomes revealed that the results
of surgery remained relatively constant over time. Regard-
less of the treatment group, the improvements in neck pain,
arm pain, and COMI scores persisted throughout the 5 years
of observation. Although only borderline statistically signif-
icant, arm pain relief showed a tendency for more favorable
results with TDA than with AIF, with an NNT of 7. Again,
larger studies are needed to confirm our findings with a higher
precision.
Table 1
Matching study: patient characteristics in matched patients (n=380) and non-matched patients (n=359)
Patient characteristics
Matched patients Non-matched AIF
patients (n=359)TDA (n=190) AIF (n=190) p-Value
Mean age in years (SD) 44.4 (7.5) 44.2 (7.7) .71 49.2 (6.8)
Age range 22.5–58.4 23.8–59.9 — 26.9–60.0
Female [%] 53.7 55.3 .76 56.6
DD [%] 24.7 22.1 .54 24.0
DH [%] 92.6 87.9 .12 90.0
No previous treatment [%] 9.5 9.0
1.0
21.2
<6 months conservative treatment [%] 60 60.5 40.7
6–12 months conservative treatment [%] 15.3 15.8 19.2
>12 months conservative treatment [%] 15.3 14.7 18.9
ASA 1 [%] 55.3 65.3
.13
54.6
ASA 2 [%] 42.6 32.6 42.6
ASA>2 [%] 2.1 2.1 2.8
C3/4 [%] 1.1 2.6
.54
2.8
C4/5 [%] 4.2 5.8 8.1
C5/6 [%] 48.4 49.5 44.0
C6/7 [%] 46.3 42.1 45.1
Time from operation to last available follow-up examination [months] (SD) 16.8 (8.1) 16.7 (7.8) .86 12.7 (8.2)
Neck pain baseline (SD) 5.4 (2.7) 5.6 (2.9) .55 5.8 (2.8)
Arm pain baseline (SD) 6.2 (2.6) 6.2 (2.8) .96 6.5 (2.6)
COMI score baseline (SD) 7.5 (1.7) 7.4 (1.8) .45 7.2 (1.9)
TDA, total disc arthroplasty; AIF, anterior interbody fusion; COMI, Core Outcome Measures Index; SD, standard deviation; DD, degenerative disc, DH,
disc herniation; ASA, American Society of Anesthesiologists score.
Note: Paired t test and Chi-square test were used for comparisons between the matched pairs, as appropriate.
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Overall, our analyses provide confirmation that AIF is sim-
ilarly effective in the different populations, whereas TDA
seems to work significantly better within the restricted in-
clusion criteria (possibly reflecting tighter indications for
surgery) of RCTs and our matched analysis. Whereas other
studies have found a slight but constant decrease of neck pain
and arm pain in the 5 years after TDA [25], we did not see
any such change; in addition, we found no significant dif-
ferences between the (smaller) TDA and AIF groups in their
long-term outcomes.
Research implications
The results of randomized controlled trials have been criti-
cized for their limited applicability to everyday clinical practice
[13,26–28]. Several factors can affect the external validity of
the results of any study. First, the study setting determines
the patients to which the study results will apply. One im-
portant issue here is the definition of eligibility criteria. For
example, investigators may decide to only recruit young pa-
tients who are likely to respond well to spinal surgery. Pre-
randomization ineligibility of up to 90% has been reported
due to narrow inclusion criteria of clinical trials [29], which
has the potential to severely restrict the generalizability of
trial results. In our cohort the situation was less accentu-
ated: about three quarters of the patients in the Spine Tango
registry were comparable to the patients in the available trials,
and only the remaining quarter had one or more of the
“typical” exclusion criteria used in the RCTs. It appears that
the available RCTs used a pragmatic (rather than a tightly con-
trolled explanatory) approach [30] in that they did not overly
restrict their study samples but strove to measure treatment
effectiveness in a setting similar to clinical practice. Never-
theless, because of the complete absence of inclusion criteria
Table 2
Outcomes measured in the three studies
Matching study (n=739)
Outcome
TDA
(n=190)
AIF
(n=190) Mean difference 95% CI p-Value
Neck pain last available COMI follow-up (SE) 2.7 (0.2) 3.3 (0.2) 0.6 0.0–1.2 .04
Neck pain change (SE) 2.7 (0.2) 2.3 (0.2) −0.5 −1.1–0.2 .16
Arm pain last available COMI follow-up (SE) 2.2 (0.2) 2.9 (0.2) 0.7 0.1–1.3 .02
Arm pain change (SE) 4.0 (0.3) 3.3 (0.3) −0.7 −1.5–0.0 .06
COMI score last available COMI follow-up (SE) 2.8 (0.2) 3.7 (0.2) 0.8 0.2–1.4 .01
COMI score change (SE) 4.7 (0.2) 3.7 (0.2) −1.0 −1.6–−0.4 <.01
Atypical patients study (n=248)
Outcome
TDA
(n=27)
AIF
(n=221)
Adjusted mean
difference 95% CI p-Value
Neck pain last available COMI follow-up (SE) 2.6 (0.5) 2.7 (0.2) 0.1 −1.0–1.2 .85
Neck pain change (SE) 2.7 (0.7) 2.6 (0.2) −0.1 −1.5–1.2 .84
Arm pain last available COMI follow-up (SE) 2.2 (0.6) 2.5 (0.2) 0.3 −0.9–1.5 .65
Arm pain change (SE) 3.4 (0.7) 3.1 (0.3) −0.3 −1.7–1.2 .73
COMI score last available COMI follow-up (SE) 3.1 (0.6) 3.3 (0.2) 0.2 −0.9–1.4 .70
COMI score change (SE) 3.9 (0.6) 3.6 (0.2) −0.3 −1.5–0.9 .61
Long-term follow-up study (n=149)
Outcome
TDA
(n=55)
AIF
(n=94)
Adjusted mean
difference 95% CI p-Value
Short-term outcome
Neck pain last available COMI follow-up (SE) 2.1 (0.4) 3.4 (0.3) 1.3 0.4–2.3 <.01
Neck pain change (SE) 3.0 (0.4) 2.2 (0.3) −0.9 −1.9–0.2 .11
Arm pain last available COMI follow-up (SE) 2.1 (0.4) 3.1 (0.3) 1.0 0.0–2.0 .05
Arm pain change (SE) 3.7 (0.5) 3.0 (0.4) −0.7 −2.0–0.6 .27
COMI score last available COMI follow-up (SE) 2.2 (0.4) 3.6 (0.3) 1.4 0.4–2.3 <.01
COMI score change (SE) 5.2 (0.4) 3.7 (0.3) −1.5 −2.6–−0.4 <.01
Longer-term outcome
Neck pain last available COMI follow-up (SE) 2.4 (0.4) 3.2 (0.3) 0.7 −0.2–1.7 .14
Neck pain change (SE) 2.7 (0.4) 2.4 (0.4) −0.3 −1.3–0.8 .65
Arm pain last available COMI follow-up (SE) 2.0 (0.4) 3.0 (0.3) 1.0 0.0–2.0 .05
Arm pain change (SE) 3.8 (0.5) 3.1 (0.4) −0.7 −2.0–0.5 .25
COMI score last available COMI follow-up (SE) 2.6 (0.4) 3.5 (0.3) 0.9 −0.1–1.9 .09
COMI score change (SE) 4.8 (0.5) 3.8 (0.3) −1.0 −2.2–0.1 .08
TDA, total disc arthroplasty; AIF, anterior interbody fusion; COMI, Core Outcome Measures Index; SE, standard error; CI, confidence interval.
Note: Multivariable linear regression models allowing for patient age, operated segment and follow-up time were used to obtain adjusted estimates of
mean differences.
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in the registry we were able to analyze 248 patients outside
the spectrum of the trials. The documentation of these atyp-
ical patients is one of the major strengths of clinical registries.
The second question affecting the external validity of trial
results is whether the outcome measured is relevant in clin-
ical practice. For practical reasons, investigators often choose
to only measure the short-term efficacy of treatments. But an
initial response to surgery is not necessarily a good predic-
tor of long-term benefit. The authors of the Cochrane review
considered it an important limitation that the available RCTs
comparing TDA and AIF followed their patients for only 2
years, and they expressed the hope that evidence of the longer-
term outcome would be available for future updates of the
review. In view of the high costs associated with long-term
follow-up of patients within a controlled trial, it may be more
efficient to undertake well-designed observational studies at
Fig. 2. Neck and arm pain and COMI scores at baseline and short-term follow-up (Left) and longer-term follow-up (Right). Unadjusted estimates and stan-
dard deviations are shown.
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this stage. There is no controlled allocation of patients to treat-
ment groups in observational studies, which simplifies their
design and administration and reduces costs. Interestingly, the
lack of randomization does not seem to generally affect the
estimates of treatment effectiveness. As also seen in our first
study, RCTs and observational studies often report similar
results: Benson and Hartz reviewed 83 RCTs and 53 obser-
vational studies and found that in only 2 out of 19 therapeutic
comparisons did the estimates of the treatment effects in ob-
servational studies lie outside the 95% CI for the combined
effect in the RCTs [31]. Concato et al. reviewed the medical
literature over a 5-year period and concluded that the results
of well-designed observational studies with either a cohort
or a case-control design did not systematically overestimate
the magnitude of the effect of treatment as compared with
that based on RCTs on the same topic [32]. Bhandari et al.
showed that, when adjusting for important risk factors, the
results of observational studies (n=13) on revision and mor-
tality rates after internal fixation of femoral neck fracture were
similar to those from RCTs (n=14) [33]. Previous registry
studies have also shown similar results to RCTs for the treat-
ments examined in the present study [34] as well as for other
spine surgical treatments such as balloon kyphoplasty [35].
Finally, the success of new treatments depends on how
safe and acceptable they prove to be in practice. Again, reg-
istries are well suited to answer these research questions. They
allow independent high-quality observational studies in routine
care. If the appropriate statistical models are used to esti-
mate treatment effectiveness (eg, propensity score adjustment),
these studies can help answer the important questions about
what happens when RCT results are applied to real-life clin-
ical practice.
Limitations
Spine Tango is a voluntary registry, making it potentially
prone to selection bias at several levels. The participating
clinics are not necessarily representative of all spine surgi-
cal centers in their countries. However, our study was based
on data from 35 hospitals in 8 countries, including a range
from small regional hospitals to university clinics and large
spine centers. There was no control as to whether the par-
ticipating clinics documented all their patients in Spine Tango
or whether a selection of cases occurred. Further, within docu-
mented patients, we cannot know whether incomplete follow-
up reporting occurred at random or not. These challenges
Patient characteristics TDA (n=27) AIF (n=221) p-Value
Mean age in years (SD) 53.8 (12.8) 61.1 (11.5) .003
Age range 27.3–76.3 26.4–88.7 —
Female [%] 33.3 48.4 .14
DD [%] 51.9 39.8 .23
DH [%] 70.4 78.7 .32
No previous treatment [%] 11.1 14.0
.47
<6 months conservative treatment [%] 33.3 40.7
6–12 months conservative treatment [%] 18.5 22.2
>12 months conservative treatment [%] 37.0 23.1
ASA 1 [%] 40.7 27.6
.24ASA 2 [%] 55.6 61.1
ASA>2 [%] 3.7 11.3
C3/4 [%] — 10.0
.037
C4/5 [%] 7.4 11.8
C5/6 [%] 63.0 33.5
C6/7 [%] 18.5 24.4
C7/T1 [%] 11.1 20.4
Time from operation to last available follow-up examination [months] (SD) 17.5 (7.5) 14.2 (8.0) .033
Neck pain baseline (SD) 5.6 (3.2) 5.2 (2.9) .52
Arm pain baseline (SD) 5.8 (2.9) 5.8 (2.7) .88
COMI score baseline (SD) 7.1 (2.3) 6.9 (2.0) .47
Reasons for exclusion from matching study
Age≥60 years [%] 40.7 65.6 .012
Spondylosis [%] 50.0 41.9 .50
C7–T1 [%] 11.1 20.4 0.25
Spondylolisthesis [%] 3.7 3.2 1.0
Facet joint arthritis [%] — 11.5 1.0
Trauma [%] 3.7 — 0.11
TDA, total disc arthroplasty; AIF, anterior interbody fusion; COMI, Core Outcome Measures Index; SD, standard deviation; DD, degenerative disc; DH,
disc herniation; ASA, American Society of Anesthesiologists score.
Note: Wilcoxon rank-sum test and Chi-square test were used for comparisons between the treatment groups, as appropriate. Statistically significant dif-
ferences are in bold.
Table 3
Atypical sample study: patient characteristics and reasons for exclusion from matching study (n=248)
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apply to many studies (including some controlled trials) and
can probably only be met by audits and other monitoring
tools that ensure the quality of documentation for all
participants.
Expectation bias is another potential problem of obser-
vational registry data collected in an open-label fashion or
indeed of non-blinded RCTs. Patients may be biased in their
reporting of outcome when they know what surgical proce-
dure they have received, with more favorable results being
expected for the “novel” treatment arm. However, in con-
trast to an RCT—in which patients must be explicitly informed
about the nature of the trial and the competing treatments
under investigation—patients in a registry may not be aware
of having received a “less sophisticated” alternative, or the
latter may not even have been an option at the time of their
treatment.
Finally, observational studies are not able to control for
all potential confounding variables. Even with sophisticated
analytical methods such as propensity score adjustment, there
is always a risk of bias due to unmeasured covariates.
Way forward
No single study design is able to comprehensively assess
a given surgical treatment through all its stages of evaluation,
from initial efficacy testing to the establishment of real-
world effectiveness and cost-effectiveness compared with other
treatment options. In 1996 Black stated, “randomized trials
provide an indication of the minimum effect of an interven-
tion whereas observational studies offer an estimate of the
maximum effect. If this is the case, policymakers need data
from both approaches when making decisions about health ser-
vices, and neither should reign supreme” [14]. More recently
Wouter and colleagues suggested that both prospective con-
trolled trials and postmarketing registries are necessary to
demonstrate the safety and effectiveness of new implant devices
[36]. We share these views. The randomized controlled trial
is the established “gold standard” of study designs to answer
the question as to whether a new treatment can work in a con-
trolled setting. Ideally, these RCTs demonstrate whether the
new treatment works better than (or is at least equal to) the
current standard treatment modality, rather than using placebo
as a comparator. Once the superiority (or non-inferiority) of
the new treatment has been established, further studies may
be needed to assess the effectiveness of the new treatment for
patients in whom it was not initially examined [37].
Consistent and sufficiently detailed data capture in regis-
tries like Spine Tango can give us important knowledge about
new treatments and their most effective and safe applica-
tion [25,35,38]. Mandatory high coverage registries such as
Swespine [39] or SWISSspine [25,35] have provided solid
data about new treatments and present key information to
policymakers, supplementary to that delivered by RCTs. From
the process point of view, a well-integrated documentation
system, which many of the Spine Tango participants have
achieved, may be less cumbersome for the clinical work-
flow than an on-and-off data collection in clinical studies. The
need for cost-effective, multi-sourced, and widely shareable
data collection has never been greater [40]. The interest in
registries is constantly growing, and rightly so.
Patient characteristics TDA (n=55) AIF (n=94) p-Value
Mean age in years (SD) 44.3 (8.7) 50.6 (10.9) .001
Age range 22.5–62.6 24.1–81.7 —
Female [%] 50.9 56.4 .52
DD [%] 38.2 37.2 .91
DH [%] 80.0 79.8 .98
No previous treatment [%] 5.5 8.5 .81
<6 months conservative treatment [%] 50.9 44.7
6–12 months conservative treatment [%] 18.2 17.0
>12 months conservative treatment [%] 25.5 29.8
ASA 1 [%] 61.8 51.1 .43
ASA 2 [%] 36.4 45.7
ASA>2 [%] 1.8 3.2
C3/4 [%] — 3.2 .23
C4/5 [%] 3.6 6.4
C5/6 [%] 56.4 44.7
C6/7 [%] 40 41.5
C7/T1 [%] — 4.3
Neck pain baseline (SD) 5.3 (2.5) 5.5 (2.4) .53
Arm pain baseline (SD) 6.0 (2.3) 6.0 (2.7) .88
COMI score baseline (SD) 7.5 (1.8) 7.2 (2.1) .55
TDA, total disc arthroplasty; AIF, anterior interbody fusion; COMI, Core Outcome Measures Index; SD,
standard deviation; DD, degenerative disc; DH, disc herniation; ASA, American Society of Anesthesiologists
score.
Note: Wilcoxon rank-sum test and Chi-square test were used for comparisons between the treatment groups,
as appropriate. Statistically significant differences are in bold.
Table 4
Longer-term follow-up study: patient characteristics (n=149)
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Appendix: Supplementary material
Supplementary data to this article can be found online at
doi:10.1016/j.spinee.2015.11.056.
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